Your browser doesn't support javascript.
loading
Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
Yonsei med. j ; Yonsei med. j;: 48-55, 2020.
Article in En | WPRIM | ID: wpr-782124
Responsible library: WPRO
Full text: 1 Index: WPRIM Main subject: Ulcer / Biological Products / Biological Therapy / Colitis, Ulcerative / Follow-Up Studies / Colectomy / Asian People / Emergency Service, Hospital / Adalimumab / Infliximab Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Yonsei med. j Year: 2020 Type: Article
Full text: 1 Index: WPRIM Main subject: Ulcer / Biological Products / Biological Therapy / Colitis, Ulcerative / Follow-Up Studies / Colectomy / Asian People / Emergency Service, Hospital / Adalimumab / Infliximab Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Yonsei med. j Year: 2020 Type: Article